| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/26/2006 | WO2005070467A3 Method of protecting sensitive molecules from a photopolymerizing environment |
| 01/26/2006 | WO2005055808A3 Compositions and methods to diagnose and treat lung cancer |
| 01/26/2006 | WO2005014037A3 Polysaccharide-protein conjugate vaccines |
| 01/26/2006 | US20060020024 TNP-470 species, polymer conjugates and use thereof |
| 01/26/2006 | US20060019911 Drug-carrier complexes and methods of use thereof |
| 01/26/2006 | US20060019885 Modified bryodin 1 with reduced immunogenicity |
| 01/26/2006 | US20060019877 Hasylated polypeptides |
| 01/26/2006 | US20060019876 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 01/26/2006 | US20060019872 Oral formulations for poorly absorptive hydrophilic drugs |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060018972 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 01/26/2006 | US20060018962 Sustained release formulation of tramadol |
| 01/26/2006 | US20060018961 Compression formed preparation and method for manufacturing same |
| 01/26/2006 | US20060018959 Solid drug for oral use |
| 01/26/2006 | US20060018956 Dermal application system for aminolevulinic acid-derivatives |
| 01/26/2006 | US20060018949 Injectable biodegradable drug delivery system |
| 01/26/2006 | US20060018914 Novel antibody conjugates reactive with human carcinomas |
| 01/26/2006 | US20060018911 Design of therapeutics and therapeutics |
| 01/26/2006 | US20060018888 Suicidal mutant leishmania vaccine |
| 01/26/2006 | US20060018852 cosmetic and dermatological compositions containing hydrocortisone, a glycol and a thickening or gelling agent; chemical stability |
| 01/26/2006 | US20060018849 Cosmetic or dermatological preparations of the oil-in-water type |
| 01/26/2006 | US20060018847 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations |
| 01/26/2006 | US20060018826 Biologic modulations with nanoparticles |
| 01/26/2006 | DE19938668B4 Tränenersatzmittel Artificial tears |
| 01/26/2006 | CA2573783A1 Cyanine dyes conjugated with antibodies for the diagnosis of micrometastasis |
| 01/26/2006 | CA2573245A1 Multivalent vla-4 antagonists comprising polymer moieties |
| 01/26/2006 | CA2572765A1 Compound having improved bioefficiency when administered in a multidose regimen |
| 01/26/2006 | CA2570825A1 Use of a steroid for enhancement of skin permeability |
| 01/25/2006 | EP1619210A1 DDS compounds and method for assaying the same |
| 01/25/2006 | EP1618898A2 Methods for regulating angiogenesis |
| 01/25/2006 | EP1618897A1 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 01/25/2006 | EP1618896A2 Dissolvable oxides for biological applications |
| 01/25/2006 | EP1618895A1 Composition containing medicine extremely slightly soluble in water and method for preparation thereof |
| 01/25/2006 | EP1618894A1 Composition for injection |
| 01/25/2006 | EP1618892A1 Instrument for inducing cytokine and method of inducing cytokine |
| 01/25/2006 | EP1618889A2 Influenza Vaccine |
| 01/25/2006 | EP1618884A1 Instrument for inducing cytokine and method of inducing cytokine |
| 01/25/2006 | EP1618880A1 Use of compounds derived from 2,3-dehydronaringenin for the treatment of inflammatory processes and pharmaceutical composition containing said derivatives |
| 01/25/2006 | EP1618879A1 Injectable formulations of taxanes for cad treatment |
| 01/25/2006 | EP1618878A1 Body-temperature lowering depressant |
| 01/25/2006 | EP1618195A2 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
| 01/25/2006 | EP1618124A2 Prophylactic and therapeutic benefits of new class of immune stimulating peptides |
| 01/25/2006 | EP1617873A2 Mitomycin conjugates cleavable by thiols |
| 01/25/2006 | EP1617872A2 Methods and compositions for enhancing immune response |
| 01/25/2006 | EP1617871A2 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 01/25/2006 | EP1617870A2 Single chain antigen-binding polypeptides for polymer conjugation |
| 01/25/2006 | EP1617861A2 Human serum albumin-free stabilised interferon liquid formulations |
| 01/25/2006 | EP1617847A2 Methods for the controlled delivery of pharmacologically active compounds |
| 01/25/2006 | EP1617845A2 Compositions and methods for induction of opioid receptors |
| 01/25/2006 | EP1617827A1 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances |
| 01/25/2006 | EP1617825A2 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |
| 01/25/2006 | EP1617823A1 A composition material for transmucosal delivery |
| 01/25/2006 | EP1617821A1 Chrono delivery formulations and method of treating atrial fibrillation |
| 01/25/2006 | EP1617820A2 Dry power inhaler devices and dry power formulations for enhancing dosing efficiency |
| 01/25/2006 | EP1617815A2 Process for making gel films |
| 01/25/2006 | EP1392241A4 System for osmotic delivery of pharmaceutically active agents |
| 01/25/2006 | EP1245232B1 Oral solid preparation |
| 01/25/2006 | EP1135127B1 New pharmaceutical composition and the process for its preparation |
| 01/25/2006 | EP1080202B1 Convection-enhanced delivery of aav vectors encoding aadc |
| 01/25/2006 | EP1001757B1 Fast-acting analgesic |
| 01/25/2006 | CN1726285A Methods and compositions for immunization against HIV |
| 01/25/2006 | CN1726183A Cardiolipin molecules and method of synthesis |
| 01/25/2006 | CN1726049A Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 01/25/2006 | CN1726045A Freeze-dried interferon-gamma composition for transpulmonary administration and inhalation system therefor |
| 01/25/2006 | CN1726043A Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 01/25/2006 | CN1726038A Tiotropium containing HFC solution formulations |
| 01/25/2006 | CN1726032A Pharmaceutical compositions of sertaconazole for vaginal use |
| 01/25/2006 | CN1726028A Solid drug for oral use |
| 01/25/2006 | CN1726027A Controlled release preparations comprising tramadol and topiramate |
| 01/25/2006 | CN1726017A Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 01/25/2006 | CN1726014A Novel dry powder inhalation system for transpulmonary administration |
| 01/25/2006 | CN1726011A Stable topiramate formulations |
| 01/25/2006 | CN1726008A Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 01/25/2006 | CN1724073A Suspension-aid agent for vaccine of coccidiosis |
| 01/25/2006 | CN1724072A Medicine-carried degradable type lacrimal duct embolus, and its prepn. method |
| 01/25/2006 | CN1724066A Controlled release composition and method of producing the same |
| 01/25/2006 | CN1723908A Gelatin micro-particles carried with dichloromethylene diphosphonate, and its prepn. method |
| 01/25/2006 | CN1723904A pH sensing controlable nanometer particle carried with 5-Fu and its prepn. method |
| 01/25/2006 | CN1723872A Oil-in-water emulsified composition |
| 01/25/2006 | CN1238056C Medicine releasing system of aliphatic polylactone mixture |
| 01/25/2006 | CN1237981C Ginkgo leaf oral disintegrating tablet and its preparation method |
| 01/25/2006 | CN1237970C Inhalant containing tiotropium salt solution |
| 01/25/2006 | CN1237960C Preparation method of aspirin microsphere |
| 01/25/2006 | CN1237959C Process for preparing pharmaceutical compositions for use with soft capsule |
| 01/25/2006 | CN1237958C Drug tablet composition of non slow-release and chewing |
| 01/24/2006 | US6989452 Anticancer agents |
| 01/24/2006 | US6989437 Exposing alpha -keratin molecules comprising reactive pendant groups to silicone crosslinking agent to form covalent interprotein crosslinks |
| 01/24/2006 | US6989436 Stabilization of cardiac troponin I subunits and complexes |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989381 Containing s cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. |
| 01/24/2006 | US6989373 By injecting a biocompatible solution, with a given intrinsic viscosity, similar to a fatty acid mixture normally present in a healthy fat pad; treating heel pain |
| 01/24/2006 | US6989365 Methods of treatment with erythropoietin and albumin fusion protein |
| 01/24/2006 | US6989253 Biological compositions and methods for treatment of testicular cancer |
| 01/24/2006 | US6989166 Soft drink replacer |
| 01/24/2006 | US6989161 Mixture of lycopene, lutein, ellagic acid, quercetin, hesperidin andepigallocatechin |
| 01/24/2006 | US6989159 Pharmaceutical compositions containing lithium carbonate |
| 01/24/2006 | US6989157 Microbiocides; bactericides; antiinflammatory agents; fungicides; viricides |
| 01/24/2006 | US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated |
| 01/24/2006 | US6989155 Particles comprising amino acid such as leucine and optionally with drug mixtures formed by aerosol condensation or spray drying, for use as inhalants; antiasthmatics |
| 01/24/2006 | US6989153 Radiation sensitive liposomes |